Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes. [electronic resource]
- Vaccine Sep 2014
- 5357-62 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1873-2518
10.1016/j.vaccine.2014.07.014 doi
Adolescent Antibodies, Neutralizing--blood Antibodies, Viral--blood Child Cross Protection Female Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 Human papillomavirus 16 Human papillomavirus 18 Humans Immunization Programs Neutralization Tests Papillomavirus Infections--prevention & control Papillomavirus Vaccines--therapeutic use